third-generation irreversible EGFR-TKI, treats NSCLC with EGFR Ex19Del and L858R mutations, targets EGFRm patients, central nervous system activity,
Sale!
Lucius
Replica: Osimertinib EGFR-TKI for NSCLC with EGFR Mutations
Original price was: $725.00.$566.00Current price is: $566.00.
third-generation irreversible EGFR-TKI, treats NSCLC with EGFR Ex19Del and L858R mutations, targets EGFRm patients, central nervous system activity,
Reviews
There are no reviews yet.